Recipharm completes Blow-fill-seal expansion at Kaysersberg facility Mar 15, 2018 Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a…
Cambrex to expand its High Point, NC Facility Aug 31, 2017 Cambrex Corporation announced that it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq. ft. analytical…
Hebron Technology wins design and implementation project Bid at Tianjin Chas esun May 25, 2017 Hebron Technology won a bid on the design and implementation of an oil-free compressed air pipe project at a pharmaceutical production facility owned…
Takeda, Harrington to advance development of rare disease therapeutics Apr 29, 2017 Takeda Pharmaceutical has entered into a multi-year partnership with Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to…
Sutro Biopharma appoints Joseph M. Lobacki as Director Apr 27, 2017 Sutro Biopharma Inc named Crestovo CEO and COO Joseph M. Lobacki to its board of directors. Mr. Lobacki previously served as chief commercial…
Recipharm opens new GMP suite for clinical trial material Apr 25, 2017 Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM)…
Amcor’s New On-Site Bottle Manufacturing Drives Efficiency and Sustainability at Campbell’s Plant Apr 25, 2017 Amcor Rigid Plastics expands its relationship with long-time customer Campbell Soup Co. with the opening of an on-site bottle manufacturing operation…
UBP selects GE Flexfactory platform to new facility in Hsinchu Industrial park Apr 25, 2017 Ge announced that United BioPharma Inc. (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Hsinchu…
Recipharm delivers first serialised batch to Saudi Arabia Apr 23, 2017 Recipharm, the contract development and manufacturing organisation (CDMO), has delivered its first batch of serialised drug products to Saudi Arabia,…
ReForm Biologics Appoints John M. Sorvillo as CEO Apr 20, 2017 ReForm Biologics, a pharmaceutical technology company that develops proprietary excipients to improve biologic formulations, announced that the…